xpression VI -Carolin meets HANNA- Holistic Analysis of loNgterm survivors with ovariaN cAncer (ENGOT-ov40/NOGGO S13/Swiss-GO-1).

 In Switzerland, every year, approximately 800 women are diagnosed with ovarian, fallopian tube or peritoneal cancer. These diseases are among the most complicated and prognostically unfavorable clinical pictures in medicine.

Fortunately, in daily clinical practice, we increasingly meet women diagnosed with ovarian, fallopian tube or peritoneal cancer who have been disease-free for over five years, so-called long-term survivors. As a result hereof, clinical research has gained interest in these patients, with or without a recurrence of cancer, with a long standing disease-free period. However, as of today, only little scientific data is available on this specific group of patients.

The Expression VI-Carolin meets HANNA- study specifically aims to collect scientific data on long-term survivors diagnosed with ovarial cancer, to identify specific factors, which are characteristic for this exceptional group of patients. 

Expression VI -Caroline meets HANNA- Holistic Analysis of loNgterm survivors with ovariaN cAncer (ENGOT-ov40/NOGGO S13/Swiss-GO-1).

With Expression VI, new scientific information is accumulated. This project has been developed by the North-East German Society for Gynecological Oncology and the European Center of Excellence for Ovarian Cancer of the Charité – Universitätsmedizin Berlin. This project is supported by the German Foundation for Ovarian Cancer, the DIWA network, and is carried out worldwide as part of the international study groups GCIG and ENGOT.  https://carolinmeetshanna.com

For additional information, please contact the Swiss-GO office or ask a physician to contact the Swiss-GO office: This email address is being protected from spambots. You need JavaScript enabled to view it..

Swiss-GO represents the Swiss participating sites in this ENGOT study. In Switzerland currently, over 193 patients are taking part in the study (as of June 2024).